BioSpace News Archive

PIC1 positioned as a novel pharmacological intervention to improve survival and cognitive outcomes for newborns affected by devastating disease

Feb. 6, 2020 14:30 UTC ROYAL OAK, Mich.--( BUSINESS WIRE )-- Immunis.AI, a privately held immunogenomics company with a patented liquid biopsy platform, today announced that its President and Chief Executive Officer, Mark McDonough, will present at the BIO CEO & Investor Conference being held in New York City from February 10-11, 2020. Date: Tuesday, February 11 th Time: 10:00 AM Track: Diagnostics Venue: Ziegfeld Room, New York Marriott Marquis

A well-known market intelligence company, Infiniti Research, has announced the completion of its latest article on identifying key regenerative medicine manufacturing challenges.

Evolent Health, Inc., a company providing an integrated value-based care platform to the nation’s leading provider and payer organizations, will release its fourth quarter and full year 2019 operating results on Tuesday, February 25, 2020 after market close, with a conference call to follow at 5:00 p.m. Eastern Time..

The Akesis Galaxy® RTx, an advanced gamma stereotactic radiosurgery system with continuous 360º rotational technology, has received 510 clearance from the U.S. Food and Drug Administration.

Addus HomeCare Corporation, a provider of home care services, announced that it will release earnings for the fourth quarter and year ended December 31, 2019, on Thursday, February 27, 2020, after the market close.

Veterinary Technician Leader is a Member of Purdue University, College of Veterinary Medicine

SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest success story on identifying new cost reduction opportunities and reducing procurement spend by 30% for a company in the UK pharmaceutical market.

eMindful, the leading provider of purpose-driven mindfulness programs that improve health and productivity and lower healthcare costs, today announced it has appointed Seth Feuerstein, MD, JD, and Julius Mokrauer, managing director for Evolve Ventures and Evolve Foundation, to its Board of Directors.

Foamix Pharmaceuticals Ltd. and Menlo Therapeutics Inc. announced that the shareholders of Foamix and stockholders of Menlo voted to approve all shareholder and stockholder proposals necessary to complete the previously announced merger at their respective shareholder / stockholder meetings.